After a slight rebound in April, lab stocks continue to exhibit strength so far in May. Over the past five weeks, the 14 publicly traded labs tracked by the G-2 Reports Laboratory Stock lab stocks are up 3 percent and 14 percent over the past 13 weeks for the week ended May 22, 2009. So far in 2009, the Index is up 10 percent. The Nasdaq also continues to post gains, although the S&P 500 continues to decline. For 2009, the Nasdaq is up 3.7 percent, while the S&P 500 is down 4.8 percent so far this year.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2009 - Table of Contents

LIR June 2009 (full PDF issue)

G-2 Reports March Survey Finds Test Volume Growth Slows to Less Than 1% During First Quarter; Lab Directors Expect 1.4% Growth for 2009

H1N1 Pandemic Threat, Health Care Overhaul Underscore Key National Priorities for Labs

CAP, ASCP Join ACLU Suit Over Breast Cancer Gene Patents

CMS Denies Reimbursement for Gene-Based Warfarin Testing; Proposes Clinical Trial Coverage

Medicare Part B Lab Spending Up 3.3% to $7.3 Billion in 2008

Inside the Lab Industry: CDC Limits Lab Industry’s Role in H1N1 Flu Diagnosis Due to IP, Reagent Supply Concerns

PLUS Diagnostics Opens West Coast Lab; Plans to Launch Hematology/Oncology Testing Services This Year

Rosetta Genomics Sells Parkway Clinical Labs for $2.5 Million in Management Buy-Out

Lab Stocks Continue to Gather Strength; Up 3% Over Five Weeks, 10% for 2009

Industry Buzz: OIG Finds Improper Medicaid Spending on Lab Services